Financials

News Discussions Technicals Forecast Seasonals

NRXP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of NRX Pharmaceuticals, Inc.

Total assets of NRXP for Q2 24 is 5.26 M USD, 38.97% more than the previous Q1 24. And total liabilities increased by 25.44% in Q2 24 to 23.66 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—